EMEA-000292-PIP01-08-M03

Key facts

Invented name
Glybera
Active substance
alipogene tiparvovec
Therapeutic area
Cardiovascular diseases
Decision number
P/0285/2016
PIP number
EMEA-000292-PIP01-08-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hyperchylomicronaemia
Route(s) of administration
intramuscular use
Contact for public enquiries
uniQure biopharma B.V.
United States
E-mail: m.agarwal@uniqure.com 
Tel.  +1 3399 707027
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating